{"id":1068436,"date":"2023-11-16T15:07:52","date_gmt":"2023-11-16T20:07:52","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/amolyt-pharma-named-biotech-company-of-the-year-at-the-lsx-european-lifestars-awards\/"},"modified":"2024-08-18T11:47:17","modified_gmt":"2024-08-18T15:47:17","slug":"amolyt-pharma-named-biotech-company-of-the-year-at-the-lsx-european-lifestars-awards","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/amolyt-pharma-named-biotech-company-of-the-year-at-the-lsx-european-lifestars-awards.php","title":{"rendered":"Amolyt Pharma Named \u2018Biotech Company of the Year\u2019 at the LSX European Lifestars Awards"},"content":{"rendered":"<p><![CDATA[LYON, France and CAMBRIDGE, Mass., Nov.  16, 2023  (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, has been awarded \u2018Biotech Company of the Year 2023\u2019 at the annual LSX, European Lifestars Awards Ceremony, held on November 13th in London, U.K.]]><\/p>\n<p>See the original post here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2023\/11\/16\/2781765\/0\/en\/Amolyt-Pharma-Named-Biotech-Company-of-the-Year-at-the-LSX-European-Lifestars-Awards.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Amolyt Pharma Named \u2018Biotech Company of the Year\u2019 at the LSX European Lifestars Awards\">Amolyt Pharma Named \u2018Biotech Company of the Year\u2019 at the LSX European Lifestars Awards<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post here: Amolyt Pharma Named \u2018Biotech Company of the Year\u2019 at the LSX European Lifestars Awards <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/amolyt-pharma-named-biotech-company-of-the-year-at-the-lsx-european-lifestars-awards.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068436","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068436"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068436"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068436\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}